BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30602217)

  • 1. Preoperative Metabolic Tumor Volume
    Lee SH; Hwang HK; Lee WJ; Yun M; Kang CM
    Gut Liver; 2019 May; 13(3):356-365. PubMed ID: 30602217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer.
    Kang CM; Lee SH; Hwang HK; Yun M; Lee WJ
    Medicine (Baltimore); 2016 Mar; 95(9):e2595. PubMed ID: 26945350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically determined type of 18F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer.
    Chong JU; Hwang HK; Lee JH; Yun M; Kang CM; Lee WJ
    PLoS One; 2017; 12(2):e0172606. PubMed ID: 28235029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival.
    Kim HR; Seo M; Nah YW; Park HW; Park SH
    Nucl Med Commun; 2018 Jul; 39(7):691-698. PubMed ID: 29893751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
    J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of metabolic tumor volume measured by 18F-FDG PET for regional lymph node status in patients with esophageal cancer.
    I HS; Kim SJ; Kim IJ; Kim K
    Clin Nucl Med; 2012 May; 37(5):442-6. PubMed ID: 22475892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of volumetric parameters measured by F-18 FDG PET/CT for lymph node status in patients with surgically resected rectal cancer.
    Jo HJ; Kim SJ; Kim IJ; Kim S
    Ann Nucl Med; 2014 Apr; 28(3):196-202. PubMed ID: 24532377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma.
    Myssayev A; Myssayev A; Ideguchi R; Eguchi S; Adachi T; Sumida Y; Tobinaga S; Uetani M; Kudo T
    PLoS One; 2019; 14(1):e0210178. PubMed ID: 30629646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximum Standard Uptake Value as a Clinical Biomarker for Detecting Loss of SMAD4 Expression and Early Systemic Tumor Recurrence in Resected Left-Sided Pancreatic Cancer.
    Kang CM; Hwang HK; Park J; Kim C; Cho SK; Yun M; Lee WJ
    Medicine (Baltimore); 2016 Apr; 95(17):e3452. PubMed ID: 27124039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer.
    Imai H; Doi R; Kanazawa H; Kamo N; Koizumi M; Masui T; Iwanaga Y; Kawaguchi Y; Takada Y; Isoda H; Uemoto S
    Int J Clin Oncol; 2010 Jun; 15(3):294-300. PubMed ID: 20232101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
    ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer.
    Aktas GE; Karamustafaoğlu YA; Balta C; Süt N; Sarikaya İ; Sarikaya A
    Nucl Med Commun; 2018 Nov; 39(11):995-1004. PubMed ID: 30188416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of metabolic tumor volume as measured by fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in nasopharyngeal carcinoma.
    Yoon YH; Lee SH; Hong SL; Kim SJ; Roh HJ; Cho KS
    Int Forum Allergy Rhinol; 2014 Oct; 4(10):845-50. PubMed ID: 25223964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Value of
    Bang J; Park HL; Yoo IR; Shin HI; Kim GJ; Sun DI; Kim SY
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
    Chang S; Kim SJ
    Cancer Biother Radiopharm; 2016 Feb; 31(1):1-6. PubMed ID: 26844846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
    Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
    Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.